Article Versions Notes

Fethi M, Rojo-Bezares B, Arfaoui A, Dziri R, Chichón G, Barguellil F, López M, El Asli MS, Toledano P, Ouzari H-I, et al. High Prevalence of GES-5 Variant and Co-Expression of VIM-2 and GES-45 among Clinical Pseudomonas aeruginosa Strains in Tunisia. Antibiotics. 2023; 12(9):1394. https://doi.org/10.3390/antibiotics12091394

Fethi, Meha, Beatriz Rojo-Bezares, Ameni Arfaoui, Raoudha Dziri, Gabriela Chichón, Farouk Barguellil, María López, Mohamed Selim El Asli, Paula Toledano, Hadda-Imen Ouzari, and et al. 2023. "High Prevalence of GES-5 Variant and Co-Expression of VIM-2 and GES-45 among Clinical Pseudomonas aeruginosa Strains in Tunisia" Antibiotics 12, no. 9: 1394. https://doi.org/10.3390/antibiotics12091394

Fethi, M., Rojo-Bezares, B., Arfaoui, A., Dziri, R., Chichón, G., Barguellil, F., López, M., El Asli, M. S., Toledano, P., Ouzari, H. -I., Sáenz, Y., & Klibi, N. (2023). High Prevalence of GES-5 Variant and Co-Expression of VIM-2 and GES-45 among Clinical Pseudomonas aeruginosa Strains in Tunisia. Antibiotics, 12(9), 1394. https://doi.org/10.3390/antibiotics12091394